Belfort%252520cedex%25252fa-study-of-telitacicept-for-the-treatment-of-moderately-to-severely-active-systemic-lupus-erythematosus%25252fa-study-of-telitacicept-for-the-treatment-of-moderately-to-severely-active-systemic-lupus-erythematosus, France